Top compounds associated with response to NLRP3


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.32 3e-21
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 3e-21
mRNA linifanib GDSC1000 pan-cancer AAC 0.31 4e-18
mRNA AC220 GDSC1000 pan-cancer AAC 0.29 2e-16
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 3e-16
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.23 1e-13
mRNA PD318088 CTRPv2 pan-cancer AAC 0.24 5e-12
mRNA Sorafenib CCLE pan-cancer AAC 0.31 1e-11
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 2e-11
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.35 2e-11
Download CSV